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Reduced nephron endowment in the neonates of Indigenous Australian peoples 
Abstract 
Rates of chronic kidney disease (CKD) among Indigenous groups in Australia exceed non-Indigenous 
rates eight-fold. Using kidney volume as a surrogate for nephron number, we carried out a study to 
determine if Indigenous neonates have a smaller kidney volume (and thus a reduced nephron number) 
from birth compared with non-Indigenous neonates. We recruited term and preterm neonates (weeks) at 
a tertiary care neonatal unit over a 12 months period. Preterm neonates were assessed (renal sonography 
and renal function measurement) at 32 weeks corrected age (CA) and again at 38 weeks CA when blood 
pressure was also measured. All term neonates were assessed in the first post-natal week, including renal 
sonography, renal function and blood pressure measurement. The primary outcome measured was total 
kidney volume (TKV) and estimated glomerular filtration rate (eGFR) was a secondary outcome. Data was 
available for 44 preterm (11 Indigenous) and 39 term (13 Indigenous) neonates. TKV of Indigenous 
neonates was significantly lower at 32 weeks [12.0 (2.0) v. 15.4 (5.1) ml; P=0.03] and 38 weeks CA [18.6 
(4.0) v. 22.6 (5.9) ml; P=0.04] respectively. Term Indigenous neonates also had smaller kidney volumes 
compared with non-Indigenous neonates. Despite a smaller kidney volume (and reduced nephron 
number), Indigenous neonates did not have a significantly lower eGFR. Indigenous neonates achieve 
similar eGFRs to Non-Indigenous neonates, presumably through a higher single nephron filtration rate. 
This places Indigenous neonates at a greater risk of long-term kidney damage later in life. 
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Rates of chronic kidney disease (CKD) among Indigenous groups in Australia exceed non-Indigenous rates eight-fold. Using kidney volume as a
surrogate for nephron number, we carried out a study to determine if Indigenous neonates have a smaller kidney volume (and thus a reduced
nephron number) from birth compared with non-Indigenous neonates. We recruited term and preterm neonates (<32 weeks) at a tertiary care
neonatal unit over a 12 months period. Preterm neonates were assessed (renal sonography and renal function measurement) at 32 weeks corrected
age (CA) and again at 38 weeks CA when blood pressure was also measured. All term neonates were assessed in the first post-natal week, including
renal sonography, renal function and blood pressure measurement. The primary outcome measured was total kidney volume (TKV) and estimated
glomerular filtration rate (eGFR) was a secondary outcome. Data was available for 44 preterm (11 Indigenous) and 39 term (13 Indigenous)
neonates. TKV of Indigenous neonates was significantly lower at 32 weeks [12.0 (2.0) v. 15.4 (5.1) ml; P= 0.03] and 38 weeks CA [18.6 (4.0) v.
22.6 (5.9) ml; P= 0.04] respectively. Term Indigenous neonates also had smaller kidney volumes compared with non-Indigenous neonates.
Despite a smaller kidney volume (and reduced nephron number), Indigenous neonates did not have a significantly lower eGFR. Indigenous
neonates achieve similar eGFRs to Non-Indigenous neonates, presumably through a higher single nephron filtration rate. This places Indigenous
neonates at a greater risk of long-term kidney damage later in life.
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Introduction
The Indigenous community of Australia, known collectively as
the Aboriginal and Torres Strait Islander people, are one of the
most socially disadvantaged groups of people in Australia. They
make up 2.5% (approximately half a million people) of the
Australian population and have a life expectancy that is 17 years
lower than the rest of the population.1 The perinatal mortality
rate for Indigenous neonates is ~1.5 times higher than that of
non-Indigenous neonates.1 The proportion of Indigenous low
birth weight (LBW; birth weight <2500 g) neonates is 12.3%,
which is double that of LBW neonates found amongst non-
Indigenous neonates (6.3%).2 Hoy et al.3 observed that up to
35% of adults in Indigenous populations were born with LBW.
In addition, the percentage of preterm neonates born to Indi-
genous women in 2009 is 13.1%, which is almost 1.5 times
higher than that of non-Indigenous mothers (8.0%).2
Chronic kidney disease (CKD) is a major contributor to
the disparity in life expectancy between Indigenous and
non-Indigenous Australians. A study by McDonald et al.4
showed that CKD rate among Indigenous people exceeded
non-Indigenous rate by eight-fold and the mean age at the start
of renal replacement therapy was 10 years earlier. The reason
for these disparities remains unclear, but researchers have
shown a strong association between LBW and renal disease in
this population.5 A study by Hoy et al.3,6 in various Australian
Indigenous populations established an association between
LBW and an increased risk of CKD in these communities.
In addition, histopathological studies have demonstrated that
Australian Indigenous adults have lower number of nephrons,
which could also be attributed to suboptimal intrauterine
conditions.6 According to Brenner’s7 hypothesis, low nephron
number triggers a vicious cycle that is associated with glomerular
hyperfiltration, glomerular damage, proteinuria, hypertension,
and long-term progression to CKD.
All studies to date showing an association between LBW
and CKD in Indigenous people3,5,6,8 were conducted in adult
populations. Information regarding birth weight was retro-
spectively obtained from medical records and LBW was
considered as one homogenous group by these investigators.
The investigators did not make any distinction between the
causes of LBW. In recent years, evidence from animal study,9
autopsy findings,10 and epidemiological data11 has indicated
that prematurity, independent of birth weight, results in
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abnormal renal development including further reductions in
nephron number, which predisposes to development of CKD.
Since nephrogenesis is completed between 34 and 36 weeks of
gestation, individuals are born with their full complement
of nephrons;12 i.e. their nephron number is fixed for life at
that time. Therefore, if extrauterine kidney development is
impaired as has been shown in animal and human studies then
preterm neonates are also at risk of oligonephronia. Furthermore,
if they are of LBW, the oligonephronia is likely to be more severe.
There have been numerous studies conducted in Indigenous
children and adults describing the natural history of CKD, but
there are no published studies that estimate nephron numbers
of Australian Indigenous newborn neonates. The only accurate
method for determining nephron number is to count them
at autopsy.10 As this is not possible in the clinical setting,
kidney volume is often used as a surrogate marker for nephron
number.13–15
We postulated that an Indigenous neonate is more likely to
have a smaller kidney volume (and therefore a reduced nephron
number) from birth. To test this hypothesis, we compared the
kidney volumes of a cohort of LBW and preterm Indigenous
neonates with the kidney volumes of a similar cohort of non-
Indigenous neonates.
Methods
This prospective observational study was performed at the
Department of Neonatology, Townsville Hospital, Northern
Queensland, Australia, a tertiary perinatal centre for a region two-
and-a-half times the size of France and with more than 10,000
births annually with ~17% to Indigenous mothers.16 The study
period lasted for 12 months. The Townsville Health District
Human Research Ethics Committee approved this study, which
was conducted in accordance with the tenets of the Declaration of
Helsinki. Written consent was obtained from parents of all neo-
nates who participated in this study. The hospital adheres to the
national guideline on determining the Indigenous status of a
patient and that is through self report.17 The health professional
or hospital administrative officer asks for the Indigenous status of
a patient. The parents determine a neonate’s Indigenous status
and that information is then recorded in the medical records. An
Indigenous reference group guided the investigators during every
phase of this study. The patients recruited into this study were
part of a larger study that also investigated the relationship
between retinal microvasculature and birth weight; the findings
of that study are discussed elsewhere.
Preterm neonates at <32 weeks of gestation admitted to the
department during the study period were eligible to participate
in this study. Patients with congenital abnormalities or syn-
dromes were excluded. Preterm neonates were recruited and
followed until discharge. Once recruited, the preterm patients
underwent a first assessment (weight, length, renal sonography
and renal function measurement) at 32 weeks corrected age (CA)
and a second assessment at 38 weeks CA (weight, length, renal
sonography, renal function, and blood pressure measurements).
CA for the preterm neonates was defined as follows: CA=
gestational age at birth (weeks)+ postnatal age in weeks.
Term neonates (gestation more than 37 weeks) were also
recruited into this study. Once recruited, all term neonates
underwent blood pressure measurement, kidney ultrasounds
and renal function measurements within the first week of life.
Birth weight and length were also recorded and these neonates
were classified according to their birth weight: those with birth
weights <2500 g were classified as LBW neonates, while those
weighing 2500–4499 g were classified as normal birth weight
(NBW) neonates. Neonates who needed respiratory support or
surgery, neonates of diabetic mothers, macrosomic neonates
(those with a birth weight >90th percentile), and those with
congenital syndromes, renal or chromosomal abnormalities
were excluded from the study.
All kidney ultrasounds were obtained using the Philips IU22
Ultrasound System (Philips Healthcare, Andover, MA, USA)
with a compact curvilinear 5–8MHz frequency transducer.
Renal length (L), anteroposterior diameter (AP), and transverse
diameter (W) were measured for both kidneys. Kidney volume
was calculated according to the following formula: (π/6×L×
W×AP).18 The total kidney volume (TKV) (right kidney
volume+ left kidney volume) was then calculated. All ultrasound
scans of the kidneys were performed by a single sonographer who
was blinded to the clinical information. The intra-class coefficient
for intra-observer variability was 0.85 (95% confidence interval:
0.73–0.91). Weight measurements were performed with an
electronic infant weighing scale (Seca 727 Electronic neonate
scale, Seca Deutschland, Hamburg, Germany). The length
measurement (measured from head to toe) was carried out with
the infant lying supine and with the body, hips, and knees
straightened; measurements were taken twice and then averaged.
The blood pressure was obtained using a non-invasive blood
pressure recording system (Dash 4000Monitor; GEHealthCare,
Waukesha, WI, USA). An infant cuff was applied to the right
upper arm with the infant calm and lying supine. Three succes-
sive BP recordings were taken at 2 min intervals and the average
was then calculated.
Venous blood was collected through a peripheral venepuncture
for serum creatinine (SCr) (μmol/l) and Cystatin C (Cys C) (mg/l)
measurements from each patient on the same day that the renal
sonogram was obtained. Serum Cys C was measured using a
commercially available kit according to the manufacturer’s
instructions (Beckman Coulter, Gentian AS,Moss, Norway). The
coefficient of variation (CV) for this measurement was 6%.
A Creatinine/Cys C-based prediction equation was then used
to calculate the estimated glomerular filtration rate (eGFR)
as follows: eGFR (ml/min/1.73m2)= (507.76× e0.003×height)/
(Cys C0.635× SCr0.547).19 None of the neonates in this study
received a prolonged course of nephrotoxic medications and none
developed acute kidney injury.
Variables with normal distribution were presented as
mean (standard deviation), whereas those without normal dis-
tribution were presented as medians (inter-quartile range).
A Student’s t-test and χ2 test were performed where appropriate.
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A P value< 0.05 was considered statistically significant. Statis-
tical analyses were performed using Stata Version 11.0 statistical
software (StataCorp, College Station, TX, USA).
Results
Preterm neonates
A total of 288 preterm neonates were admitted to the depart-
ment during the study period. Forty-nine preterm neonates
out of 112 who fulfilled the recruitment criteria were recruited;
two died and three were transferred back to regional hos-
pitals, which made them unavailable for assessment. The
deceased preterm neonates were small for their gestational age
(SGA, birth weight< 10th percentile). Therefore, data from
44 preterm neonates (all appropriate for gestational age) were
available for analysis (18 female, 26 male; 11 Indigenous,
33 non-Indigenous). The Indigenous neonates recruited in our
study were more preterm [26.4 (2.1) v. 28.6 (2.2) weeks;
P= 0.003] and smaller [965 (298) v. 1193 (336) g; P= 0.036]
than the non-Indigenous neonates, respectively. The patients’
clinical data and kidney volume measurements at 32 and
38 weeks CA are summarized in Table 1. At 38 weeks CA,
there was no difference in body weight and blood pressure. The
kidney volumes of Indigenous neonates were significantly lower at
32 weeks [12.0 (2.0) v. 15.4 (5.1) ml; P=0.03] and 38 weeks
CA [18.6 (4.0) v. 22.6 (5.9) ml; P=0.04], respectively. Table 1
shows the comparison between Indigenous and non-Indigenous
preterm neonates at 32 and 38 weeks CA. Using pooled TKV
measurements taken at 32 and 38 weeks CA, Fig. 1 shows the
comparison of the extra uterine renal growth trajectories for
Indigenous and non-Indigenous preterm neonates from 32 to
38 weeks of gestation. Analysis of covariance shows a significant
difference between the slopes (P=0.004).
Term neonates
The number of term infant admissions to the Department of
Neonatology at the completion of the recruitment period was
524 neonates, of which 227 fulfilled the recruitment criteria.
Consent was obtained for 43 neonates. Four patients were
excluded because of renal abnormalities (hydronephrosis).
Complete data were obtained and analysed from 39 neonates
(17 male, 22 female; 13 LBW). There were 13 Indigenous
neonates (five male, eight female) in this cohort and nine (one
male; eight females) of them were LBW. Out of 26 NBW
neonates (15 male, 11 female), four neonates (all male) were
Indigenous. The proportion of Indigenous LBW neonates
was significantly higher (χ2= 11.31; P= 0.001). Gestational age
of Indigenous neonates were not significantly different from non-
Indigenous neonates [38.6 (1.4) v. 38.7 (1.4) weeks; P= 0.80]
Indigenous neonates had lower mean birth weights [2646 (844)
v. 3143 (509) g; P= 0.03] and TKVs [18.4 (4.8) v. 24.3 (6.3) ml;
P= 0.01] but there were no difference in Cys C [1.4 (1.2–1.4) v.
1.1 (1.0–1.4) mg/l; P= 0.20], eGFR [74.8 (69.4–79.8) v. 79.3
(71.7–88.2) ml/min/1.73 m2; P= 0.30] and blood pressure
(58.2± 2.2 v. 59.2± 7.0 mmHg; P= 0.59) compared with
Table 1. Comparison between Indigenous and non-Indigenous preterm neonates at 32 and 38 weeks CA
Assessment at 32 weeks CA Assessment at 38 weeks CA
Indigenous Non-Indigenous P-value Indigenous Non-Indigenous P-value
Number of patients (Male/Female) 11 (6/5) 33 (21/12) – 11 33 –
Weight (g) 1334 (152) 1481 (279) 0.09 2636 (337) 2558 (427) 0.60
Total kidney volume (ml) 12.0 (2.0) 15.4 (5.1) 0.03 18.6 (4.0) 22.6 (5.9) 0.04
Total kidney volume/body weight (ml/kg) 9.1 (2.1) 10.6 (2.7) 0.09 7.1 (1.4) 8.9 (2.2) 0.01
eGFR (ml/min/1.73 m2) 65.3 [56.0–78.0] 65.6 [53.3–79.8] 0.98 67.5 [62.4–74.6] 74.5[69.0–77.7] 0.09
Cystatin C (mg/l) 1.41 [1.24–1.57] 1.40 [1.20–1.54] 0.64 1.58 [1.37–1.74] 1.36 [1.27–1.53] 0.08
eGFR/Total kidney volume (ml/min/1.73 m2)/ml 6.0 [4.3–6.4] 4.4 [3.7–5.1] 0.05 3.8 [3.3–4.5] 3.4 [2.8–4.0] 0.18
Mean blood pressure (mm Hg) NA NA – 54.8± 10.0 60.7± 9.9 0.23
CA, corrected age; NA, not available.
eGFR was derived from the following formula: eGFR (ml/min/1.73 m2)= [507.76× e0.003× height]/[Cys C0.635× SCr0.547].19
Fig. 1. The difference in extra uterine renal growth trajectories
between preterm Indigenous and non-Indigenous neonates from
32 to 38 weeks of gestation [using pooled total kidney volume
(TKV) measurements taken at 32 and 38 weeks CA] (P= 0.004).
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non-Indigenous neonates. When kidney volume was correc-
ted for birth weight (TKV/BW), Indigenous neonates had
smaller TKV/BW ratios compared with non-Indigenous
neonates in both the NBW and LBW cohorts but the
differences were not statistically significant (6.4± 1.1 v.
7.5± 1.8 ml/kg; P= 0.24 ) and (7.5± 1.5 v. 9.3± 2.5 ml/kg;
P= 0.11) respectively.
In both preterm and term cohorts, there was no significant
difference in eGFR and Cys C levels for Indigenous neonates
compared with non-Indigenous neonates despite the former
having a significantly smaller kidney volume.
Discussion
In this study we were able to demonstrate that preterm
and term Indigenous neonates have smaller kidney volumes
compared with non-Indigenous neonates. They also appear
to have difference growth trajectories. Using the best
available evidence that kidney volume is a proxy indicator for
nephron number, we conclude that Indigenous neonates
were more likely to have fewer nephrons compared with
non-Indigenous neonates. Despite this, they did not have sig-
nificantly lower eGFRs compared with their non-Indigenous
contemporaries. The eGFR is the product of the single-
nephron GFR multiplied by total nephron number.7 The
kidneys can compensate by increasing the single-nephron GFR
(hyperfiltration) when the number of nephrons diminish.7
Therefore, nephrons in Indigenous neonates appear to be
hyperfiltrating.
In 1981, Hostetter et al.20 demonstrated that loss of
nephrons in rats after removal of 5/6 of the kidney mass led
to a compensatory increase in the single-nephron GFR in
the remaining functioning nephrons. Brenner21 subsequently
proposed that this compensatory mechanism of single-
nephron hyperfiltration leads to proteinuria, hypertension,
glomerulosclerosis and ultimately CKD. The association
between LBW, poor nephron endowment, and single-nephron
hyperfiltration is also known as the ‘Barker-Brenner
hypothesis’.22
In Indigenous adult Australians, the pathogenesis of CKD is
likely to be the result of a ‘multi-hit’ mechanism.23 In many,
LBW and prematurity may result in a low nephron endowment
and single nephron hyperfiltration, representing the first hit.
Indigenous children have been shown to have a high incidence
of post-streptococcal glomerulonephritis, often followed by
significant and prolonged albuminuria, thereby representing
a second hit.24 Subsequent ‘hits’ may include haemolytic
uraemic syndrome, renal stones, and acute kidney injury25 and
Type 2 diabetes mellitus.25
It is currently unknown if nephron protection should
begin at birth.26 A large community-based screening pro-
gramme of young Indigenous school children using urine
analysis (with dipstick) and blood pressure monitoring failed to
show any significant diffrence.27 The investigators concluded
that the increased risk for CKD seen in Indigenous adults is
not yet manifest in schoolchildren. It remains to be determined
if other techniques of detecting glomerular injury, such as the
use of urinary nephrin levels, would make screening more
useful.28 This would then pave the way for clinical trials of
nephroprotective strategies in this at risk population.
Despite the significant results, one of the main limitations
of the study was the small sample size, which precluded
meaningful subgroup analysis. Participation in our study is
voluntary. Parents are not required to give a reason if they
decline to participate. A few parents (voluntarily) told us that
they were not keen for their babies to undergo procedures
that are not medically indicated. Others told us that that
they were unable to come back for investigation such as ultra-
sound kidney or venipuncture. Maternal data and fetal growth
data have been difficult to acquire. We plan to follow these
neonates upon discharge from the hospital through outreach
clinics, but this represents a significant challenge since some of
the remote Indigenous communities where these neonates
originate are more than 1000 km from our centre. It remains
to be seen how these neonatal findings will be manifest in
later childhood.
Conclusion
In this study, we were able to demonstrate that Indigenous
preterm and term neonates have smaller kidney volumes (hence
lower nephron endowment) compared with non-Indigenous
neonates. However, despite this they have similar eGFR most
probably secondary to single nephron hyperfiltration. This may
represent the beginning of the cascade of events or ‘multi-hits’,
which finally result in the development of CKD in Indigenous
people at a much younger age than their non-Indigenous
contemporaries. Further work to address the causes, detection
and treatment of this perinatal kidney deficit is warranted to
address the future health of this population.
Acknowledgements
The Indigenous Reference Group for Research, Townsville
Hospital, Queensland Health.
Financial Support





The Townsville Health District Human Research Ethics
Committee approved this study, which was conducted in
accordance with the tenets of the Declaration of Helsinki.
34 Y. Kandasamy et al.
References
1. Pink B, Allbon P. The Health and Welfare of Australia’s Aboriginal
and Torres Strait Islander Peoples. ABS Cat. No. 4704.0; AIHW
Cat. No. IHW 21, 2008. Australian Bureau of Statistics and
Australian Institute of Health and Welfare: Canberra. http://
www.aihw.gov.au/publications/index.cfm/title/10583 (accessed
Sep 2013).
2. AIHW. Australia’s Mothers and Neonates 2009. Perinatal Statistics
Series No. 25. Cat. No. PER 52, 2009. AIHW: Canberra. http://
www.aihw.gov.au/publication-detail/?id=10737420870
(accessed Sep 2013).
3. Hoy WE, Rees M, Kile E, Mathews JD, Wang Z. A new
dimension to the Barker hypothesis: low birthweight
and susceptibility to renal disease. Kidney Int. 1999; 56,
1072–1077.
4. McDonald SP, Russ GR. Current incidence, treatment patterns
and outcome of end-stage renal disease among Indigenous groups
in Australia and New Zealand. Nephrology (Carlton). 2003; 8,
42–48.
5. HoyWE, Rees M, Kile E, et al. Low birthweight and renal disease
in Australian aborigines. Lancet. 1998; 352, 1826–1827.
6. Hoy WE, Hughson MD, Singh GR, Douglas-Denton R,
Bertram JF. Reduced nephron number and glomerulomegaly in
Australian Aborigines: a group at high risk for renal disease and
hypertension. Kidney Int. 2006; 70, 104–110.
7. Brenner BM, Garcia DL, Anderson S. Glomeruli and blood
pressure. Less of one, more the other? Am J Hypertens. 1988;
1(Pt 1), 335–347.
8. White SL, Perkovic V, Cass A, et al. Is low birth weight an
antecedent of CKD in later life? A systematic review of
observational studies. Am J Kidney Dis. 2009; 54, 248–261.
9. Sutherland MR, Gubhaju L, Black MJ. Stereological assessment
of renal development in a baboon model of preterm birth.
Am J Nephrol. 2011; 33(Suppl 1), 25–33.
10. Rodriguez MM, Gomez AH, Abitbol CL, et al.
Histomorphometric analysis of postnatal glomerulogenesis
in extremely preterm neonates. Pediatr Dev Pathol. 2004;
7, 17–25.
11. Hodgin JB, Rasoulpour M, Markowitz GS, D’Agati VD. Very
low birth weight is a risk factor for secondary focal segmental
glomerulosclerosis. Clin J Am Soc Nephrol. 2009; 4, 71–76.
12. Schreuder MF. Safety in glomerular numbers. Pediatr Nephrol.
2012; 27, 1881–1887.
13. Nyengaard JR, Bendtsen TF. Glomerular number and size in
relation to age, kidney weight, and body surface in normal man.
Anat Rec. 1992; 232, 194–201.
14. Gubhaju L, Black MJ. The baboon as a good model for studies of
human kidney development. Pediatr Res. 2005; 58, 505–509.
15. Zhang Z, Quinlan J, Hoy W, et al. A common RET variant is
associated with reduced newborn kidney size and function. J Am
Soc Nephrol. 2008; 19, 2027–2034.
16. Queensland Health. Indigenous Health Indicators. 2011. Tropical
Regional Services: Cairns, North Queensland.
17. Australian Institute of Health and Welfare. National Best Practice
Guidelines for Collecting Indigenous Status in Health Data Sets. Cat.
no. IHW 29. 2010. AIHW: Canberra.
18. Hricak H, Lieto RP. Sonographic determination of renal volume.
Radiology. 1983; 148, 311–312.
19. Zappitelli M, Parvex P, Joseph L, et al. Derivation and validation
of cystatin C-based prediction equations for GFR in children. Am
J Kidney Dis. 2006; 48, 221–230.
20. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA,
Brenner BM. Hyperfiltration in remnant nephrons: a potentially
adverse response to renal ablation. Am J Physiol. 1981; 241,
F85–F93.
21. Brenner BM, Lawler EV, Mackenzie HS. The hyperfiltration
theory: a paradigm shift in nephrology. Kidney Int. 1996; 49,
1774–1777.
22. Feig DI, Rodriguez-Iturbe B, Nakagawa T, Johnson RJ. Nephron
number, uric acid, and renal microvascular disease in the
pathogenesis of essential hypertension. Hypertension. 2006; 48,
25–26.
23. Nenov VD, Taal MW, Sakharova OV, Brenner BM. Multi-hit
nature of chronic renal disease. Curr Opin Nephrol Hypertens.
2000; 9, 85–97.
24. Hoy WE, White AV, Dowling A, et al. Post-streptococcal
glomerulonephritis is a strong risk factor for chronic kidney
disease in later life. Kidney Int. 2012; 81, 1026–1032.
25. White A, Wong W, Sureshkumur P, Singh G. The burden of
kidney disease in Indigenous children of Australia and New
Zealand, epidemiology, antecedent factors and progression to
chronic kidney disease. J Paediatr Child Health. 2010; 46,
504–509.
26. Bagby SP. Developmental origins of renal disease: should
nephron protection begin at birth? Clin J Am Soc Nephrol. 2009;
4, 10–13.
27. Haysom L, Williams R, Hodson EM, et al. Natural history of
chronic kidney disease in Australian Indigenous and non-
Indigenous children: a 4-year population-based follow-up study.
Med J Aust. 2009; 190, 303–306.
28. Welsh GI, Saleem MA. Nephrin-signature molecule of the
glomerular podocyte? J Pathol. 2010; 220, 328–337.
Low birth weight, prematurity and renal disease 35
